Introduction
Migraine is more than just a severe headache. The disorder typically has a cyclic character with recurrent attacks that last hours to days and culminate in head pain, sensory hypersensitivity, and nausea. Often the attack is preceded and followed by neglected symptoms as tiredness, concentration problems, mood problems and reduction of drive or energy. As a function of frequency, migraine attacks may have a profound impact on the individual’s private and professional life [
1,
2]. Around 10% of the migraine population are affected by a chronic form, where migraine occurs on 15 or more days per month [
3]. The prevalence of migraine in the workforce, and its well-known dependence on endogenous and exogenous triggering factors, has spurred interest in understanding how the work environment can contribute to or alleviate migraine symptoms. Thus impacting both, quality of life of patients, but also productivity of the companies.
Migraine often leads to absenteeism and presenteeism, significantly affecting productivity at work. Employees experiencing migraine may find it challenging to concentrate, to complete tasks efficiently, or even to show up for work consistently. The costs associated with loss of productivity due to migraine underscore the need for employers to address this issue proactively [
4]. A very recent study showed that migraine diagnosis and severity is associated with an occupational burnout, after controlling for various psychological and work-related factors [
5]. The authors conclude that workplace adjustments would support and improve migraine patients’ participation in the work market.
Almost 90% of productivity loss associated with migraine is attributed to presenteeism [
6]. During the attack, individuals may be less than half as effective due to factors such as migraine symptoms, emotional impact, unpredictability, and the associated stigma [
7]. The repercussions of migraine-related productivity loss extend beyond the immediate workplace, impacting career choices, job status and security, financial well-being, work relationships, mood, and confidence [
8,
9]. Notably, migraines are estimated to contribute to around 15% of total presenteeism in the US workforce. Strategies to support individuals with migraine in the workplace and enhance their productivity are therefore clearly needed and should be implemented in the workspace.
Two recent studies showed that running workspace migraine education and management program may reduce absenteeism and presenteeism and thereby improve direct and indirect cost for a company [
10,
11]. In the study of Schaetz et al. the return on investment was calculated to be 490%.
Implementing workspace migraine care programs, integrating education and management initiatives, fostering a migraine-friendly work environment, optimizing migraine treatment, and advocating the needs of individuals dealing with migraine will therefore have not only an effect on the individual’s quality of life, but also direct economic impact. Here, we present a proposal for a framework to address the importance of a migraine-friendly workspace with a strategy for potential and effective implementation in Switzerland.
Discussion
Migraine is frequent and accounts for a significant disease burden that can exacerbate other health problems. In addition to mental health comorbidities, migraine can increase cardiovascular risk through mechanisms as heightened stress responses or disadvantageous lifestyle [
14]. Migraine prevention is hence a form of long-term global and brain health preservation. Indeed, the “Migraine-Friendly Workspace” initiative launched by the Swiss Headache Society (Schweizerische Kopfwehgesellschaft, SKG), is aligned with the “Swiss Brain Health Plan,” which was again initiated by the Swiss Federation of Clinical Neurosocieties (SFCNS). This preventive brain health approach reflects similar initiatives in Europe and beyond [
8] following an initiative of the European Academy of Neurology (EAN) and the World Health Organization (WHO).
Across the life span, migraine hits hardest during the decades of professional activity and therefore the majority of the related economic burden is generated by indirect costs. The situation for migraine is hence very different from most other highly prevalent diseases with incidence occurring at a higher or even very advanced age and therefore usually after retirement. This difference becomes glaringly relevant when comparing cost efficiency analyses for modern preventive migraine treatments that either consider only costs generated within the healthcare system or in a more adequate and responsible way weigh in the entire societal cost [
15].
Beyond medication and especially new but also expensive preventive drugs, an obvious leverage can be obtained from considering the exquisite sensitivity of migraine to environmental and lifestyle factors. It is therefore imperative to educate individuals with migraine but also their employers early on about this condition.
The Swiss MFWS initiative presented here provides a tangible and significant step towards better controlling but also destigmatizing this prevalent neurological condition, contributing to improved brain health and quality of life. One could even speculate if there are good reasons to have more employees with migraine in your company. Some authors speculate about advantages of migraine [
16]. And there is further evidence, that some professions are even associated with higher prevalence of migraine [
17].
Conclusion
Creating a migraine-friendly workspace is not only a matter of compassion but also a strategic business decision. The direct and indirect costs associated with migraine in the workspace underscore the importance of investing in environments that support employee’s health and productivity. By implementing practical, simple but effective changes provided by the e3-program, organizations can create inclusive workspaces that benefit both employers and employees.
References
- Agosti, R.; Parzini, C.; Findling, O.; Myers, P.; Petersen, J.A.; Ryvlin, P.; Sandor, P.; Stallmach, M.; Zecca, C.; Snellman, J.; et al. Prevalence and Burden of Migraine in Switzerland: Cross-Sectional Study in ten Specialised Headache Centres from the BECOME Study. Pain Ther. 2023, 12, 1–17. [CrossRef]
- Sokolovic, E.; Riederer, F.; Szucs, T.; Agosti, R.; Sándor, P.S. Self-reported headache among the employees of a Swiss university hospital: prevalence, disability, current treatment, and economic impact. J. Headache Pain 2013, 14, 29–29. [CrossRef]
- Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia Int J Headache. Januar 2018;38(1):1–211.
- Edmeads, J.; Mackell, J.A. The Economic Impact of Migraine: An Analysis of Direct and Indirect Costs. Headache: J. Head Face Pain 2002, 42, 501–509. [CrossRef]
- Peles, I.; Sharvit, S.; Zlotnik, Y.; Gordon, M.; Novack, V.; Waismel-Manor, R.; Ifergane, G. Migraine and work – beyond absenteeism: Migraine severity and occupational burnout – A cohort study. Cephalalgia 2024, 44. [CrossRef]
- Goetzel RZ, Long SR, Ozminkowski RJ, Hawkins K, Wang S, Lynch W. Health, absence, disability, and presenteeism cost estimates of certain physical and mental health conditions affecting U.S. employers. J Occup Environ Med. April 2004;46(4):398–412.
- Shapiro, R.E.; Nicholson, R.A.; Seng, E.K.; Buse, D.C.; Reed, M.L.; Zagar, A.J.; Ashina, S.; Muenzel, E.J.; Hutchinson, S.; Pearlman, E.M.; et al. Migraine-Related Stigma and Its Relationship to Disability, Interictal Burden, and Quality of Life. Neurology 2024, 102, e208074. [CrossRef]
- Begasse de Dhaem O, Sakai F. Migraine in the workplace. eNeurologicalSci. Juni 2022;27:100408.
- Begasse de Dhaem O. Migraines Are a Serious Problem. Employers Can Help. Harvard Business Review [Internet]. 24. Februar 2021 [zitiert 16. August 2024]; Verfügbar unter: https://hbr.org/2021/02/migraines-are-a-serious-problem-employers-can-help.
- Schaetz, L.; Rimner, T.; Pathak, P.; Fang, J.; Chandrasekhar, D.; Mueller, J.; Sandor, P.S.; Gantenbein, A.R. Employee and Employer Benefits From a Migraine Management Program: Disease Outcomes and Cost Analysis. Headache: J. Head Face Pain 2020, 60, 1947–1960. [CrossRef]
- Shimizu, T.; Sakai, F.; Miyake, H.; Sone, T.; Sato, M.; Tanabe, S.; Azuma, Y.; Dodick, D.W. Disability, quality of life, productivity impairment and employer costs of migraine in the workplace. J. Headache Pain 2021, 22, 1–11. [CrossRef]
- Eigenbrodt, A.K.; Ashina, H.; Khan, S.; Diener, H.-C.; Mitsikostas, D.D.; Sinclair, A.J.; Pozo-Rosich, P.; Martelletti, P.; Ducros, A.; Lantéri-Minet, M.; et al. Diagnosis and management of migraine in ten steps. Nat. Rev. Neurol. 2021, 17, 501–514. [CrossRef]
- Wei, D.; Chang, Y.; Lu, X.; Fan, X.; Hu, J.; Manta, O.; Kaabar, M.K.A. Association between Migraine and Workplace Social Support in the Social Context of China: Using a Validated Chinese Version of the DCSQ. Healthcare 2023, 11, 171. [CrossRef]
- Al-Hassany, L.; MaassenVanDenBrink, A.; Kurth, T. Cardiovascular Risk Scores and Migraine Status. JAMA Netw. Open 2024, 7, e2440577–e2440577. [CrossRef]
- Griffin, E.; Shirley, G.; Lee, X.Y.; Awad, S.F.; Tyagi, A.; Goadsby, P.J. An economic evaluation of eptinezumab for the preventive treatment of migraine in the UK, with consideration for natural history and work productivity. J. Headache Pain 2024, 25, 1–16. [CrossRef]
- Loder E. What is the evolutionary advantage of migraine? Cephalalgia Int J Headache. Oktober 2002;22(8):624–32.
- Evers S, Brockmann N, Summ O, Husstedt IW, Frese A. Primary headache and migraine in headache specialists - does personal history of doctors matter? Cephalalgia Int J Headache. Januar 2020;40(1):96–106.
|
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).